Cited by 195Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSirtuins and Resveratrol in Medicine

Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases

Open access
Song, Shuling, Lam, Eric W.-F., Tchkonia, Tamara, Kirkland, James L., Sun, Yu·2020·Trends in Biochemical Sciences

Abstract

Aging is a major risk factor for numerous human pathologies, including cardiovascular, metabolic, musculoskeletal, and neurodegenerative conditions and various malignancies. While our understanding of aging is far from complete, recent advances suggest that targeting fundamental aging processes can delay, prevent, or alleviate age-related disorders. Cellular senescence is physiologically beneficial in several contexts, but it has causal roles in multiple chronic diseases. New studies have illustrated the promising feasibility and safety to selectively ablate senescent cells from tissues, a therapeutic modality that holds potential for treating multiple chronic pathologies and extending human healthspan. Here, we review molecular links between cellular senescence and age-associated complications and highlight novel therapeutic avenues that may be exploited to target senescent cells in future geriatric medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2020.03.008

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The target specificity and toxicity to non-senescent cells is still a big hurdle for clinical applications of current senolytic treatments.

    “The target specificity and toxicity to non-senescent cells is still a big hurdle for clinical applications of the current senolyitc treatments.14,15”

    From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [14]

    The Bcl-2-Targeting Senolytics section says hematological toxicities of Bcl-2 inhibitors raise safety issues that may impede clinical development, and it calls for more specific agents. The claim extends that concern to current senolytic treatments generally; the Other Senolytics section instead reports that dasatinib plus quercetin kills senescent cells but not the non-senescent counterparts tested. Page numbers are unavailable in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 137 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Song, S., Lam, E. W.-F., Tchkonia, T., Kirkland, J. L., & Sun, Y.
Affiliations
  • Binzhou Medical University (CN)
  • Imperial College London (GB)
  • Mayo Clinic (US)
Corresponding author
Sun, Yu
Venue
Trends in Biochemical Sciences
Publisher
Elsevier BV
Published
2020-07
Volume
45
Issue
7
Pages
578-592
ISSN
0968-0004 (ISSN-L)
OpenAlex
W3014969606
Cited by
195
References
137
Citations by year
2026: 23 · 2025: 27 · 2024: 30 · 2023: 30 · 2022: 40 · 2021: 39 · 2020: 6
FWCI
3.67
Type
journal article
Language
en
Open access
Locations
  • Trends in Biochemical Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
  • National Institutes of Health (P01 AG062413, R37-AG013925)
  • Cancer Research UK (A12011)
  • National Key Research and Development Program of China Stem Cell and Translational Research (2016YFC1302400)
  • Breast Cancer Now (2012MayPR070, 2012NovPhD016)
  • National Institute for Health Research
  • Mayo Clinic
  • National Key Research and Development Program of China
  • Noaber Foundation
  • U.S. Department of Defense (PC111703)
  • National Natural Science Foundation of China (31871380, 81472709, 31671425)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, aging, age-related diseases, senolytics, senolytic therapy, healthspan extension, chronic disease, geriatrics, neurodegeneration, cardiovascular disease, cancer
MeSH terms
Humans, Neoplasms, Phenotype, Cellular Senescence, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review